APP下载

丁苯酞联合艾地苯醌治疗脑小血管病性认知障碍的效果

2025-08-09崔丹黄长迎

中国医学创新 2025年16期
关键词:脑小血管病丁苯

The Effect of Butylphthalide Combined with Idebenone in the Treatment of Cognitive Impairment Caused by Cerebral SmallVessel Disease/CUIDan,HUANG Changying.//Medical Innovationof China, 2025,22(16): 038-042

[Abstract]Objective:To investigatethe efectof Butylphthalide combined with Idebenone in the treatment of cognitive impairment caused bycerebralsmallvessl disease.Method:Eighty patients with cognitive impairment caused bycerebral small vessel disease who were admited tothe Department of Neurologyof Zichuan District Hospital of Traditional Chinese Medicine,Zibo City from June 2O22 to June 2O24 were selected.By using the computer random digital table method,the patients were divided into the observation group and the control group, with 40 cases in each group.The control group was treated with Butylphthalide and Sodium Chloride Injection. On this basis,the observation group was treated with Idebenone Tablets in combination.Both groups were treated for 2 months.The therapeutic efects,cognitivefunction [Montreal cognitive assessment scale (MoCA)] score,national institutes ofhealth stroke scale (NIHSS)score,activitiesof living (Barthel index)scores,cerebral hemodynamics and adverse reactions of the two groups were observed and compared.Result: The total efectiverate of treatment in the observation group was higher than that in the control group ( P lt;0.05).After treatment,the NIHSS score in the observation group was lower than thatin the control group,and the MoCA score and Barthel index score were higher than those in the control group ( P lt;0.05).After treatment,the levels of cerebral blood flow (CBF) and cerebral blood volume (CBV) in both groups increased and those in the observation group were higher than those in the control group,the mean transit time (MTT)in both groups decreased and that in the observation group was lower than that in the control group ( P lt;0.05). There was no statistically significant difference in adverse reactions between the two groups ( P gt;0.05).Conclusion:Butylphthalide and Sodium Chloride Injection combined with Idebenone Tablets is effctive in the treatment of cognitive impairment caused by cerebral small vessel disease,and can improve cognition,neurological function and life ability,with high safety.

[Key Words]Cognitive impairment caused by cerebral smallvascular diseaseIdebenoneButylphthalide and Sodium Chloride InjectionCognitive function

First-author'saddress:Department of Encephalopathy,Zichuan District Hospital of Traditional Chinese Medicine, Zibo City, Zibo 255100, China doi:10.3969/j.issn.1674-4985.2025.16.010

脑小血管病(cerebral smallvesseldisease,CSVD)是常见的血管病。脑小血管病性认知障碍(CSVCI)是CSVD引起的神经退化性状况,其主要表现为脑部微小血管的病变,进而引发认知能力持续减退,且随时间逐渐加重,在老年人口中较为常见[-2]。CSVCI的病因涉及遗传、环境和生活方式等多种因素,血管病变、炎症反应、氧化应激和神经递质失衡等均可导致CSVCI的发生,此外,高血压、糖尿病、吸烟和肥胖等传统心血管疾病的危险因素也是CSVCI的重要诱因[3-4]。丁苯酞是目前临床常采用的一种神经保护剂,其作用机制在于改善脑缺血区微循环,促进缺血区血管新生,增加缺血区脑血流,具有抗氧化和神经保护的特点[5。然而,丁苯酞在治疗CSVCI时对肝功能存在一定风险。艾地苯醌则是一种新型的神经保护剂,与丁苯酞相比,其在改善认知功能和神经功能方面显示出更大的潜力和优势。为进一步了解联合用药的价值,本文通过探究丁苯酞联合艾地苯醌治疗脑小血管病性认知障碍患者的效果,旨在为该药的临床应用提供参考。

1资料与方法

1.1一般资料

将2022年6月—2024年6月淄博市淄川区中医院80例CSVCI患者利用电脑随机数字表法分为对照组和观察组,各40例。纳入标准:(1)符合文献[7]《脑小血管病相关认知功能障碍中国诊疗指南(2019)》诊断标准,即存在认知相关症状及血管性脑损伤,经头颅磁共振(MRI)检查确诊;(2)60岁以上;(3)无严重精神障碍或其他神经疾病;(4)病历资料齐全;(5)依从性良好。排除标准:(1)药物过敏、心肝肾功能不全;(2)合并恶性肿瘤;……

登录APP查看全文

猜你喜欢

脑小血管病丁苯
丁苯酞联合高频重复经颅磁刺激对脑梗死后 吞咽障碍的影响
脑安胶囊联合丁苯酞对脑梗死患者神经功能及认知功能的影响
磁共振成像与CT在脑小血管病影像特征及诊断效能中的对比分析
依达拉奉右莰醇联合丁苯酞对急性脑梗死静脉溶栓后患者神经功能及血液流变学的影响